TSXV:ACST (Canada)  
Acasti Pharma Inc logo

Acasti Pharma Inc

C$ 0.54 (0%) Dec 5
P/E:
At Loss
P/B:
0.18
Market Cap:
C$ 24.09M ($ 17.72M)
Enterprise V:
C$ -22.20M ($ -16.33M)
Volume:
-
Avg Vol (2M):
2.81K
Also Trade In:
Volume:
-
Market Cap C$:
24.09M
Market Cap $:
17.72M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.81K
Enterprise Value C$:
-22.20M
Enterprise Value $:
-16.33M
PB Ratio:
0.18
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes.
Name Current Vs Industry Vs History
Cash-To-Debt 67.19
Equity-to-Asset 0.83
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -4.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.92
9-Day RSI 35.84
14-Day RSI 33.21
6-1 Month Momentum % -37.5
12-1 Month Momentum % -50.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.86
Quick Ratio 9.86
Cash Ratio 9.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -65.5
Name Current Vs Industry Vs History
ROE % -16.02
ROA % -14.16
ROIC % -23.76
ROC (Joel Greenblatt) % -4792.76
ROCE % -15.72

Financials (Next Earnings Date:2023-02-14 Est.)

TSXV:ACST's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.502
Beta 1.76
Volatility % 32.69
14-Day RSI 33.21
14-Day ATR (C$) 0.022947
20-Day SMA (C$) 0.592
12-1 Month Momentum % -50.33
52-Week Range (C$) 0.52 - 2.3
Shares Outstanding (Mil) 44.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acasti Pharma Inc Filings

Document Form Filing Date
No Filing Data

Acasti Pharma Inc Analysis

Share your research